Sold as Placidyl. Every FDA application for this active ingredient: 1 branded and 1 generic.
As of Nov 13, 2026, FDA lists 2 applications for Ethchlorvynol (sold as Placidyl), first approved May 10, 1961, with 0 new uses approved and 0 published complete response letters.
| May 10, 1961 | PlacidylNDA 10021 · New formulation or manufacturer | Abbvie | 14 | Discontinued |
| — | EthchlorvynolANDA 84463 | Banner Pharmacaps | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA
Abbvie